ScreenerHero

VIVS VivoSim Labs, Inc.

NAS · US · Healthcare · Biotechnology · vivosim.ai
0.1915USD-5.15%Mkt Cap: 3.18M $P/E: —

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and in…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap3.18M USD
Enterprise Value1.64M USD
Revenue (TTM)112.00K USD
Gross Profit131.00K USD
Net Income (TTM)-13.84M USD
Revenue/Share0.03 USD
Last Price0.1915 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.15
EV/Revenue14.68
P/S29.90
P/B-0.28
EPS (TTM)-4.41
EPS (Forward)—
52W Range
0.19130% of range3.870
52W High3.870 USD
52W Low0.1913 USD
Profitability
Gross Margin100.00%
Oper. Margin-15327.78%
EBITDA Margin0.00%
Profit Margin-10567.18%
ROE1259.60%
ROA-187.42%
Growth
Revenue Growth-51.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.83M USD
CapEx (TTM)—
FCF Margin-6763.73%
FCF Yield-238.50%
Net Debt-1.35M USD
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity-0.41
Current Ratio1.70
Quick Ratio0.90
Book Value/Sh-0.73 USD
Cash/Share0.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 19, 2020
Splits
Last Split1:12
Split DateMar 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.16.59M
Float14.42M
Insiders2.67%
Institutions11.09%
Short Interest
Short Ratio0.8d
Short % Float3.41%
Short % Out.3.40%
Shares Short564.68K
Short (prev mo.)751.42K
Technical
SMA 500.2912 (-34.2%)
SMA 2001.245 (-84.6%)
Beta1.49
S&P 52W Chg16.45%
Avg Vol (30d)842.59K
Avg Vol (10d)573.39K
Technical Indicators
RSI (14)27.9
MACD-0.0442
MACD Signal-0.0500
MACD Hist.+0.0058
BB Upper0.3078 USD
BB Middle0.2374 USD
BB Lower0.1670 USD
BB Width59.33%
ATR (14)0.0262 USD
Vol Ratio (20d)0.96x